SerImmune
Goleta
About SerImmune
Serimmune is a company that studies immunity to find out how environmental factors affect health and disease. Its universal serology platform utilizes bacterial display peptide library technology and sequencing to broadly profile antibody repertoires and identify antigens and epitopes associated with many diseases all in a single assay.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $21.4M
- Funding stage: M&A
- Last round: Series Unknown (Sep 2020)
- Website: serimmune.com
- Phone: 619-203-5391
Industries & Categories
Biotechnology, Health Care, Information Technology, Medical
Social Profiles
Canonical: https://fsome.com/organization/serimmune-57362 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.